Scholarlink

<p>Multiple lines of evidence implicate microRNAs (miRNAs) in major depressive disorder (MDD), including the location of miRNAs genes (MIRs) within genomic regions identified by genome wide association studies (GWAS). To investigate the role of MIRs in the genetic risk for MDD, we identified all associated single nucleotide polymorphism (SNPs) that were expression quantitative loci (eQTLs) for MIRs in brain tissues. Our analyses identified four MIRs having associated eQTLs in the credible SNP set (variants near a genetic association signal predicted to include causal variants). Based on pathway analyses of the predicted targets, we selected <i>MIR1255A</i> for functional studies and overexpressed it in human neural precursor cells (NPCs) to identify target genes in neural cells. Transcriptome analyses of the transfected cells identified 343 differentially expressed (DE) genes at an adjusted p (FDR) &lt;0.05 and an additional 276 DE genes at adjusted <i>p</i> &lt; 0.1 (total 619 genes). Of these, 14 genes were supported as genetic risk genes by fine mapping by GWAS (representation factor 1.8, <i>p</i> &lt; 0.025), with additional genes implicated in risk from biological studies (altered expression or serum levels in individuals with MDD, animal models). Notably, 157 DE genes were implicated in neurodevelopmental disorders (representation factor 1.5, <i>p</i> &lt; 3.31E-07). Gene set enrichment analyses of DE genes revealed the top categories as neurogenesis, generation of neurons, regulation of cell differentiation and neuron development. These findings support <i>MIR1255A</i> as regulator of processes critical for neurodevelopment and a contributor to genetic risk for depression.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

MIR1255A regulates pathways critical for brain development, risk genes for depression and neurodevelopmental disorders

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月30日

查看全文
  • Yu Feng,
  • Karen G. Wigg,
  • Cathy L. Barr

摘要

Multiple lines of evidence implicate microRNAs (miRNAs) in major depressive disorder (MDD), including the location of miRNAs genes (MIRs) within genomic regions identified by genome wide association studies (GWAS). To investigate the role of MIRs in the genetic risk for MDD, we identified all associated single nucleotide polymorphism (SNPs) that were expression quantitative loci (eQTLs) for MIRs in brain tissues. Our analyses identified four MIRs having associated eQTLs in the credible SNP set (variants near a genetic association signal predicted to include causal variants). Based on pathway analyses of the predicted targets, we selected MIR1255A for functional studies and overexpressed it in human neural precursor cells (NPCs) to identify target genes in neural cells. Transcriptome analyses of the transfected cells identified 343 differentially expressed (DE) genes at an adjusted p (FDR) <0.05 and an additional 276 DE genes at adjusted p < 0.1 (total 619 genes). Of these, 14 genes were supported as genetic risk genes by fine mapping by GWAS (representation factor 1.8, p < 0.025), with additional genes implicated in risk from biological studies (altered expression or serum levels in individuals with MDD, animal models). Notably, 157 DE genes were implicated in neurodevelopmental disorders (representation factor 1.5, p < 3.31E-07). Gene set enrichment analyses of DE genes revealed the top categories as neurogenesis, generation of neurons, regulation of cell differentiation and neuron development. These findings support MIR1255A as regulator of processes critical for neurodevelopment and a contributor to genetic risk for depression.